{
    "Trade/Device Name(s)": [
        "illumigene\u00ae C. difficile",
        "illumigene Molecular Diagnostic Test System",
        "illumipro-10"
    ],
    "Submitter Information": "Meridian Bioscience, Inc.",
    "510(k) Number": "K110012",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100818"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "OMN"
    ],
    "Summary Letter Date": "February 24, 2011",
    "Summary Letter Received Date": "January 3, 2011",
    "Submission Date": "December 31, 2010",
    "Regulation Number(s)": [
        "21 CFR 866.2660"
    ],
    "Regulation Name(s)": [
        "Microorganism differentiation and identification device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clostridium difficile DNA (Toxin A gene)"
    ],
    "Specimen Type(s)": [
        "Unformed human stool",
        "Human stool in Cary-Blair-based media"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "illumipro-10 Automated Isothermal Amplification and Detection System"
    ],
    "Method(s)/Technology(ies)": [
        "DNA Amplification Assay",
        "Loop-Mediated Isothermal Amplification (LAMP)"
    ],
    "Methodologies": [
        "Isothermal DNA amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for illumigene\u00ae C. difficile DNA amplification assay using isothermal LAMP technology for detection of toxigenic C. difficile in human stool",
    "Indications for Use Summary": "Qualitative assay for detection of toxigenic Clostridium difficile in stool samples from patients suspected of having Clostridium difficile-associated disease (CDAD), intended for point-of-care use",
    "fda_folder": "Microbiology"
}